FIELD: medicine, oncology. SUBSTANCE: invention shows the possibility of the complete inhibition of interaction of carcinogens with proteins and decrease the group of the enhanced oncological risk among industrial workers by 5-fold. Also, possibility of correction of immunoreactivity disorders associated with carcinogenesis using biologically active compounds (sage and clove essential oils) has been detected. Method can be used for preclinical prophylaxis of malignant neoplasm as oncological risk. EFFECT: improved method of prophylaxis. 4 tbl
Title | Year | Author | Number |
---|---|---|---|
SYNTHETIC ANTIGEN BASED ON COPOLYMERS OF N-VINYLPYRROLIDONE, CROTONIC ACID AND PARA-CROTONOYL AMINOPHENOL COMPRISING COVALENTLY JOINED 2-NAPHTHYLAMINE AS HAPTEN | 2003 |
|
RU2262515C2 |
COPOLYMERS OF N-VINYLPYRROLIDONE, CROTONIC ACID AND P- CROTONOYLAMINOPHENOL CONTAINING COVALENTLY BOUND 3-HYDROXYANTHRANILIC ACID (HAPTEN) AS SYNTHETIC ANTIGENS | 1997 |
|
RU2181127C2 |
COPOLYMERS OF N-VINYLPYRROLIDONE, CROTONIC ACID AND @-CROTONOYLAMINOPHENOL AS A POLYMERIC BASE OF SYNTHETIC ANTIGEN ON THE BASIS OF COPOLYMERS OF N-VINYLPYRROLIDONE, CROTONIC ACID AND @-CROTONOYLAMINOPHENOL, AND A METHOD OF SYNTHETIC ANTIGEN PREPARING | 0 |
|
SU1812183A1 |
BIOLOGICALLY ACTIVE FOOD SUPPLEMENT WITH CANCER-PREVENTIVE ACTION | 2016 |
|
RU2619207C1 |
CEREAL BAR FOR FEEDING WORKING WITH AMINO- AND NITRO-COMPOUNDS OF BENZENE | 2019 |
|
RU2712697C1 |
METHOD OF PREPARING CONJUGATED ANTIGENS | 0 |
|
SU1109169A1 |
METHOD OF REVEALING INITIATION OF MALIGNANT PROCESS IN HUMAN ORGANISM | 1991 |
|
RU2021612C1 |
SET FOR SCREENING ANALYSIS OF ONCOMARKER IN SERUM AND WHOLE BLOOD | 1995 |
|
RU2119167C1 |
CANCER PREVENTING AGENT | 1999 |
|
RU2159109C1 |
STRAIN OF HYBRIDOUS CULTURED MAMMALIAN CELLS, MUS MUSCULUS L - A PRODUCER OF MONOCLONAL ANTIBODIES TO VILLEBRAND FACTOR OF HUMAN BLOOD CLOTTING SYSTEM | 0 |
|
SU1693046A1 |
Authors
Dates
1997-08-27—Published
1993-07-07—Filed